Imaging of a Clickable Anticancer Iridium Catalyst.

Xiuxiu Wang,Mingli Zhu,Fei Gao,Wei,Yong Qian,Hong-Ke Liu,Jing Zhao
DOI: https://doi.org/10.1016/j.jinorgbio.2017.12.019
IF: 4.336
2018-01-01
Journal of Inorganic Biochemistry
Abstract:Iridium-based anticancer reagents are receiving increasing attention for their high cytotoxicity. Herein, by activating CH bonds in the well-known antioxidant α-phenyl-N-tert-butylnitrone (PBN), we synthesized and characterized a series of new iridium complexes. Complex 1-AMP exhibited the best antiproliferation activity towards human ovarian cancer A2780 cells. The azide group in complex 1-AMP underwent the Cu(I)-catalysed azide−alkyne cycloaddition (CuAAC) reaction and the resulting fluorescent imaging in cells suggested it mainly accumulated in mitochondria. In comparison, to eliminate cytotoxicity of Cu(I) catalyst, we conducted a reaction between complex 1-AMP and a commercialized dye via strain-promoted alkyne–azide cycloaddition (SPAAC) reaction in live cells, confirming its targeting mainly in the mitochondria. Iridium-based anticancer complexes containing a nitrone ligand and azide group may offer a useful tool to probe the mechanism of metallodrugs.
What problem does this paper attempt to address?